TNFSF13B and plasma cell myeloma: Serum levels increasing of BAFF shown in multiple myeloma patients [8, 40], but the BAFF receptor is difficult to detect on malignant plasma cells [41] and so suggesting that it has less effect on the survival of multiple myeloma cells [42].